Authors: BRECHT JG VOLMER T SCHADLICH PK LUTZELBERGER U

Citation: Jg. Brecht et al., COST-EFFECTIVENESS OF MONOCLONAL-ANTIBODY 17-1A (MAB) ADJUVANT THERAPY OF RESECTED COLON-CANCER (CC) OF STAGE DUKES C IN GERMANY - A SUBGROUP ANALYSIS, Annals of oncology, 9, 1998, pp. 179-179

Authors: LUTZELBERGER U SCHADLICH PK VOLMER T BRECHT JG

Citation: U. Lutzelberger et al., DUKES C COLORECTAL-CARCINOMA - TREATMENT COSTS OF RECURRENCE AFTER CURATIVE RESECTION IN GERMANY, Annals of oncology, 9, 1998, pp. 188-188

Authors: SCHADLICH PK LUTZELBERGER U BRECHT JG VOLMER T

Citation: Pk. Schadlich et al., MONOCLONAL-ANTIBODY 17-1A (MAB) ADJUVANT THERAPY OF RESECTED DUKES-C COLORECTAL-CARCINOMA (CRC) - A COST-EFFECTIVENESS ANALYSIS IN GERMANY, Annals of oncology, 9, 1998, pp. 198-198